Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 102, Issue 9, Pages 3372-3377Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0408506102
Keywords
autoimmunity; cytokines; dendritic cells
Categories
Funding
- NCI NIH HHS [CA 78846, R01 CA078846] Funding Source: Medline
Ask authors/readers for more resources
Cytokines, most particularly TNF and type I IFN (IFN-alphabeta), have been long considered essential elements in the development of auto-immunity. Identification of TNF in the pathogenesis of rheumatoid arthritis and TNF antagonist therapy represent successes of immunology. IFN-alphabeta plays a major role in systemic lupus erythematosus (SLE), a prototype autoimmune disease characterized by a break of tolerance to nuclear components. Here, we show that TNF regulates IFN-alpha production in vitro at two levels. First, it inhibits the generation of plasmacytoid dendritic cells (pDCs), a major producer of IFN-alphabeta, from CD34(+) hematopoietic progenitors. Second, it inhibits IFN-a release by immature pDCs exposed to influenza virus. Neutralization of endogenous TNF sustains IFN-a secretion by pDCs. These findings are clinically relevant, as five of five patients with systemic juvenile arthritis treated with TNF antagonists display overexpression of IFN-alpha-regulated genes in their blood leukocytes. These results, therefore, might provide a mechanistic explanation for the development of anti-dsDNA antibodies and lupus-like syndrome in patients undergoing anti-TNF therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available